Printed From BioPortfolio.com

APHB Is A Good Shot, ASND Keeps Inching Along, SKLN Soars, INSM To File ALIS NDA

00:06 EST 4 Jan 2018 | RTTNews

Today's Daily Dose brings you news about the number of STREAMWAY system sold by Skyline Medical in 2017; Zynerba's renewed focus on rare and near-rare neurological and psychiatric disorders; FDA clearance of Zimmer's Sidus Stem-Free Shoulder system; Ascendis Pharma's progress in TransCon Growth Hormone study and OvaScience's encouraging data on fertility treatment OvaPrime.

Original Article: APHB Is A Good Shot, ASND Keeps Inching Along, SKLN Soars, INSM To File ALIS NDA

More From BioPortfolio on "APHB Is A Good Shot, ASND Keeps Inching Along, SKLN Soars, INSM To File ALIS NDA"

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search

Relevant Topics

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention. Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...

Joint Disorders
A joint is where two or more bones come together, like the knee, hip, elbow, or shoulder. Joints can be damaged by many types of injuries or diseases, including Arthritis - inflammation of a joint causes pain, stiffness, and swelling with ...

News Quicklinks

Search Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches